Norges Bank’s Vaxcyte PCVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,228,939
Closed -$56.7M 1001
2025
Q4
$56.7M Buy
+1,228,939
New +$55M 0.01% 974
2025
Q3
Sell
-987,674
Closed -$32.1M 1117
2025
Q2
$32.1M Buy
987,674
+87,832
+10% +$2.88M ﹤0.01% 1099
2025
Q1
$34M Sell
899,842
-200,444
-18% -$16M ﹤0.01% 1087
2024
Q4
$90.1M Sell
1,100,286
-12,249
-1% -$1.22M 0.01% 735
2024
Q3
$127M Buy
1,112,535
+128,071
+13% +$11.5M 0.02% 597
2024
Q2
$74.3M Sell
984,464
-61,568
-6% -$4.19M 0.01% 750
2024
Q1
$71.5M Buy
1,046,032
+130,520
+14% +$9.04M 0.01% 781
2023
Q4
$57.5M Buy
915,512
+129,969
+17% +$6.75M 0.01% 841
2023
Q3
$40M Buy
785,543
+34,509
+5% +$1.7M 0.01% 939
2023
Q2
$37.5M Buy
751,034
+334,398
+80% +$15.9M 0.01% 995
2023
Q1
$15.6M Buy
416,636
+290,757
+231% +$12.3M ﹤0.01% 1393
2022
Q4
$6.04M Buy
+125,879
New +$4.94M ﹤0.01% 1725
2021
Q1
Sell
-20,000
Closed -$531K 2182
2020
Q4
$531K Hold
20,000
﹤0.01% 2074
2020
Q3
$988K Hold
20,000
﹤0.01% 2032
2020
Q2
$632K Buy
+20,000
New +$643K ﹤0.01% 2039

Other funds holding PCVX